Prostate cancer testing attempts to find prostate cancer in individuals at an early and potentially curable stage before symptoms have developed with the aim to treat the disease and decrease the death rate from prostate cancer. Testing for prostate cancer
Read more…

Current guidelines recommend that: All men from the age of 50 years with a life expectancy of at least 10 years should have access to a yearly PSA and DRE All men who have a family history of prostate cancer
Read more…

With systematic testing most cancers found are in a curable stage. Recent evidence has demonstrated that prostate cancer screening does save lives. A large trial recently published in the world renowned New England Journal of Medicine, demonstrated that PSA based
Read more…

Each year approximately 20000 Australian men are diagnosed with prostate cancer and over 3300 men die from a direct result of prostate cancer each year. This equates to 55 men being diagnosed with prostate cancer and 9 men dying from
Read more…

Testing for prostate cancer has potential risks and benefits. In making a decision whether or not to be tested these risks and benefits must be assessed. Potential benefits of prostate cancer testing and early diagnosis include: Diagnosing prostate cancer at
Read more…

If prostate cancer is diagnosed early and is potentially curable, there are many treatment options including: active surveillance, external beam radiotherapy, brachytherapy and radical prostatectomy. Unfortunately all potentially curative options for prostate cancer have potential side effects. These side effects
Read more…

Links to position statements on Prostate Cancer Testing There are many different recommendations regarding prostate cancer testing around the world. All have slightly different specific guidelines but they are all unanimous in that they recommend the following: The decision to
Read more…